跳至主要内容
临床试验/NCT00920166
NCT00920166已完成3 期

Growth and Tolerance in New Born Fed Formula Supplemented With Alpha-Lactalbumin and Containing a Symbiotic

Sodilac8 个研究点 分布在 1 个国家目标入组 97 人开始时间: 2007年2月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
Sodilac
入组人数
97
试验地点
8
主要终点
Growth Parameters

研究概览

简要总结

The purpose of the study is to assess growth and tolerance in new born and infant fed an experimental infant formula with reduced total protein concentration, enriched in alpha-lactalbumin and containing a symbiotic.

详细描述

This prospective, randomized, double blind, controlled study evaluated the safety and effect on growth and tolerance to an infant formula supplemented with alpha-lactalbumin and containing a symbiotic, in term infants.

Term infants with a gestational age ranging from 37 to 42 weeks and whose parents chose formula feeding were enrolled during their first eight days of life.

Both parents provided informed written consent. Infants were randomly assigned to receive either the new test formula or a control, a regular formula adapted for term infants (Modilac®1). The control formula is formulated to meet the nutritional needs of infants.

For each neonates, neonatal parameters were collected.

5 visits took place : V1 (inclusion), V2 (randomization), V3 (1 month), V4 (3 months) and V5 (6 months). During each visit, the investigator filled in observational book the anthropometric parameters (weight, height, head circumference, BMI) and pieces of information collected 3 days before by the parents (gastrointestinal tolerance parameters, daily infant behaviour and milk consumption). Global parents' contentment was evaluated as well.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 8 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Term health newborn infant with gestational age ranging from 37 to 42 weeks
  • Eutrophic
  • Non breastfed children
  • Apgar score > 5 to 7 minutes

排除标准

  • Infant presenting a metabolic, nervous, digestive or organic disease able to interfere with study
  • Evidence of protein cow milk allergy
  • Infant presenting lactose intolerance
  • Newborn whose parents did not provide informed consent
  • Newborn currently participating in another trial

结局指标

主要结局

Growth Parameters

时间窗: 1, 3 and 6 months

次要结局

  • Sensitization or allergy(1, 3 and 6 months)
  • Atopic diseases (eczema atopic, asthma, allergic rhinitis)(1, 3 and 6 months)
  • Describe the intestinal flora according to the nutrition group(1 and 6 months)
  • Clinical Tolerance(1 and 6 months)

研究者

发起方
Sodilac
申办方类型
Industry

研究点 (8)

Loading locations...

相似试验